Jerrell Shelton - Cryoport CEO and President and Director

CYRX Stock  USD 8.30  0.03  0.36%   

CEO

Mr. Jerrell W. Shelton is Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Shelton became a member of our board of directors in October 2012 and was appointed President and Chief Executive Officer of the Company in November 2012. He was appointed Chairman of the Board in October 2015. He served on the Board of Directors and standing committees of Solera Holdings, Inc. from April 2007 through November 2011. From June 2004 to May 2006, Mr. Shelton was the Chairman and CEO of Wellness, Inc., a provider of advanced, integrated hospital and clinical environments. Prior to that, he served as Visiting Executive to IBM Research and Head of IBMs WebFountain. From October 1998 to October 1999, Mr. Shelton was Chairman, President and CEO of NDC Holdings II, Inc. Between October 1996 and July 1998, he was President and CEO of Continental Graphics Holdings, Inc. And from October 1991 to July 1996, Mr. Shelton served as President and CEO of Thomson Business Information Group. Mr. Shelton has a B.S. in Business Administration from the University of Tennessee and an M.B.A. from Harvard University since 2015.
Age 79
Tenure 9 years
Address 112 Westwood Place, Brentwood, TN, United States, 37027
Phone949 470 2300
Webhttps://www.cryoportinc.com

Latest Insider Transactions

2024-11-19Disposed of 50000 shares @ 6.78View
Shelton’s extensive leadership, management, strategic planning and financial expertise through his various leadership and directorship roles in public, private and global companies, makes him wellqualified to serve as a member of the board of directors.

Jerrell Shelton Latest Insider Activity

Tracking and analyzing the buying and selling activities of Jerrell Shelton against Cryoport stock is an integral part of due diligence when investing in Cryoport. Jerrell Shelton insider activity provides valuable insight into whether Cryoport is net buyers or sellers over its current business cycle. Note, Cryoport insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cryoport'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Cryoport Management Efficiency

The company has return on total asset (ROA) of (0.0512) % which means that it has lost $0.0512 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3315) %, meaning that it created substantial loss on money invested by shareholders. Cryoport's management efficiency ratios could be used to measure how well Cryoport manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2024. Return On Capital Employed is likely to rise to -0.12 in 2024. At this time, Cryoport's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 443.8 M in 2024, whereas Other Assets are likely to drop 0.95 in 2024.
Cryoport currently holds 416 M in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Cryoport has a current ratio of 13.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cryoport's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

CEO Age

Quentin BlackfordiRhythm Technologies
45
Michael RiceBioLife Solutions
61
Peter MaagCaredx Inc
57
John HannaCaredx Inc
44
Steven ChapmanNatera Inc
45
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1999 and is headquartered in Brentwood, Tennessee. Cryoport operates under Integrated Freight Logistics classification in the United States and is traded on NASDAQ Exchange. It employs 900 people. Cryoport (CYRX) is traded on NASDAQ Exchange in USA. It is located in 112 Westwood Place, Brentwood, TN, United States, 37027 and employs 1,100 people. Cryoport is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Cryoport Leadership Team

Elected by the shareholders, the Cryoport's board of directors comprises two types of representatives: Cryoport inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cryoport. The board's role is to monitor Cryoport's management team and ensure that shareholders' interests are well served. Cryoport's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cryoport's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Stefanovich, CFO, Treasurer, Corporate Secretary
Thomas Heinzen, Vice Relations
Robert MS, CFO Treasurer
Tony Ippolito, VP Counsel
Phil Wilson, LLC Systems
Jerrell Shelton, CEO and President and Director
Edward Zecchini, Senior Officer
Mark Sawicki, Chief Officer
Raymond MD, Ex Officer
Bret Bollinger, LLC Systems
David MD, Ex Officer
Kylie Crowe, Vice Development

Cryoport Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cryoport a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cryoport Stock Analysis

When running Cryoport's price analysis, check to measure Cryoport's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryoport is operating at the current time. Most of Cryoport's value examination focuses on studying past and present price action to predict the probability of Cryoport's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryoport's price. Additionally, you may evaluate how the addition of Cryoport to your portfolios can decrease your overall portfolio volatility.